Showing results (71-80 of 1,348) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|August 17, 2019
Population Pharmacokinetics of Rolapitant in Patients With Chemotherapy-Induced Nausea and VomitingXiaodong Wang, Jing Wang, Zhi-Yi Zhang, et al.
Clinical Pharmacology in Drug Development|February 28, 2019
A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Patients With Hepatic Impairment and Healthy Matched ControlsJafar Sadik B Shaik, Susan L Ford, Yu Lou, et al.
Clinical Pharmacology in Drug Development|November 15, 2018
Pharmacokinetics of Single and Repeat Doses of Fluticasone Furoate/Umeclidinium/Vilanterol in Healthy Chinese AdultsYan Li, Huafang Li, Yucheng Sheng, et al.
Clinical Pharmacology in Drug Development|February 22, 2019
A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy SubjectsGilmour Morrison, Julie Crockett, Graham Blakey, et al.
Clinical Pharmacology in Drug Development|November 20, 2018
Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 TrialHans-Dirk Düngen, Lars Kober, Savina Nodari, et al.
Clinical Pharmacology in Drug Development|February 16, 2019
The Relative Bioavailability and Effects of Food and Acid-Reducing Agents on Filgotinib Tablets in Healthy SubjectsKacey Anderson, Hao Zheng, Mona Kotecha, et al.
Clinical Pharmacology in Drug Development|February 13, 2021
Safety of a Novel Weight Loss Combination Product Containing Orlistat and AcarboseStefan Grudén, Anders Forslund, Göran Alderborn, et al.
Clinical Pharmacology in Drug Development|February 19, 2021
First-in-Human Study for a Selective Rearranged During Transfection Tyrosine Kinase Inhibitor, GSK3352589, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy VolunteersBeth Ann Reedy, Robin O'Connor-Semmes, Kimberley Hacquoil, et al.
Clinical Pharmacology in Drug Development|March 7, 2017
Liver Disease and Fibrosis Assessment in Substance Use-Related DisordersMarija Zeremski, Anthony Martinez
Clinical Pharmacology in Drug Development|March 7, 2017
Omics for Understanding the Gut-Liver-Microbiome Axis and Precision MedicineJag Khalsa, Linda C Duffy, Gabriela Riscuta, et al.
Pageof 135